Drug Logix India is a chemical research-based pharmaceutical company established in India with the mission of providing cost-effective and time-bound high-quality key starting materials (KSMs), intermediates of Active Pharmaceutical Ingredients (APIs) and impurity synthesis services to the global pharmaceutical industry.
We are involved in the research, development and manufacturing of quality KSMs, API intermediates, and supply of synthesized impurity standards — backed by full spectroscopic characterisation including NMR, Mass, HPLC, and elemental analysis.
Read Our StoryRecent additions across our API intermediates and key starting materials — alongside impurity standards, nitrosamines and agro chemicals.
Six specialised verticals, one integrated team.
Development and manufacturing of API intermediates & KSMs — the essential building blocks in multi-step API synthesis. Our process spans route scouting, scale-up, GMP manufacturing, and rigorous quality control with mass spectrometry, NMR and HPLC.
Learn MoreBespoke, high-purity chemical compounds, intermediates, and APIs tailored to your specifications — from milligram to ton scale. We accelerate drug discovery with custom molecule development, route optimisation, and scalable solutions under GMP regulations.
Learn MoreBridging the gap between laboratory ingenuity and market-ready production. We provide comprehensive process improvement and technology transfer services — ensuring seamless, science-driven transitions from R&D to commercial manufacturing.
Learn MoreExpert synthesis, isolation, and purification of API impurities, degradation products, process impurities, and metabolites. From process impurities and forced degradation products to genotoxic impurities (GTIs), nitrosamines and drug metabolites — we handle the most challenging transformations with ICH-grade characterisation.
Learn MoreComprehensive, science-driven PMI assessment supporting ICH M7 expectations — synthetic route and process review, structural alert evaluation, QSAR-based genotoxicity assessment, ICH M7 risk classification, and a process-based control strategy delivered as an audit-ready assessment report.
Learn MoreStructured nitrosamine risk assessment for APIs, drug products, intermediates and excipients — precursor and nitrite source evaluation, formation pathway assessment, supplier and carryover risk review, risk ranking with scientific justification, and recommended mitigation and control strategies.
Learn MoreEvery batch leaves our lab with full characterisation — NMR, Mass, HPLC, and elemental analysis — because a reference standard is only as good as its COA.
Discover MoreEvery product backed by NMR, Mass, HPLC, and COA — the numbers regulators want to see.
In-stock items ship in 48 hours. Custom synthesis delivered in weeks, not months.
Sr. chemists with decades of medicinal and process chemistry experience on tap.
Strict confidentiality agreements. Your molecule stays your molecule — always.
Drop a message or call us directly. Our chemists respond within one business day with feasibility, timelines, and pricing.
Fill in the form — we respond within 24 hours.